表紙
市場調査レポート

欧州の静脈瘤治療装置市場

European Markets for Varicose Vein Treatment Devices 2014

発行 Millennium Research Group 商品コード 292012
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=105.69円で換算しております。
Back to Top
欧州の静脈瘤治療装置市場 European Markets for Varicose Vein Treatment Devices 2014
出版日: 2013年12月18日 ページ情報: 英文
概要

欧州の静脈瘤治療装置市場は、大静脈を低侵襲的に治療する方向に動いています。静脈瘤治療が未治療患者に浸透しはじめていることから、硬化療法という独占的市場セグメントは今後も成長を続ける見込みです。

当レポートでは、欧州の静脈瘤治療装置市場について調査し、欧州各国の瞳孔、臨床環境、製品概要、セグメント別市場に関する詳細な分析などをまとめ、概略下記の構成で取り上げております。

エグゼクティブサマリー

第1章 国の概要

  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • 英国
    • 人口統計と経済
    • 医療制度
    • 法規制環境

第2章 臨床環境

  • 背景
    • 静脈瘤
    • クモ状静脈
  • 処置の概要
    • 静脈内アブレーション
    • 外科ストリッピングおよび結索
    • 静脈切除術
    • 硬化療法
  • 競合する治療法
  • ガイドラインと診断パターン

第3章 製品

  • 静脈内アブレーション装置
  • 外科ストリッピング装置
  • 静脈切除装置
  • 硬化療法剤

第4章 治験

  • 静脈内アブレーション
  • 硬化療法

第5章 静脈瘤治療装置市場

  • 市場概要
  • 詳細な市場分析
  • 競合動向
  • 詳細な競合環境
  • 市場シェア
  • 近年のイベント
  • 最も有望な新興製品

第6章 静脈内アブレーション装置市場

第7章 外科的ストリッピング装置市場

第8章 静脈切除術市場

第9章硬化療法剤市場

付録

図表

目次
Product Code: RPEU11VR13

The European varicose vein treatment device market will be characterized by a shift toward less invasive procedures for treatment of large veins, at the expense of surgical procedures. The dominant market segment, sclerotherapy, will experience continued growth in response to the increasing penetration of varicose vein treatments into a fairly undertreated population.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for varicose vein treatment devices in Europe across a 10-year period.

Millennium Research Group has up-to-date reports on a wide range of medical device markets worldwide.

Questions Answered in This Report:

* Device reimbursement will play a significant role in determining the adoption of endovenous ablation procedures over the forecast period.

  • What is the current reimbursement situation for endovenous ablation procedures?
  • How will reimbursement vary by country?

* Foam sclerotherapy use will expand over the forecast period.

  • What are some of the approved sclerosing agents on the market?
  • Which countries will see greater adoption of this procedure?

* The surgical vein stripping device market will continue to grow in some countries.

  • Why do these invasive procedures continue to be popular in some countries?
  • How will the increasing availability of minimally invasive treatment options impact surgical vein stripping procedure growth?

Scope:

Geographies Covered: France, Germany, Italy, Spain, UK

Market Forecast Features: Based on primary research with industry professionals, Millennium Research Group uses its proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 10-year period (2012-2022)

Competitive Analysis: Millennium Research Group provides a detailed analysis of the competitive landscape and market shares for leading competitors.

Authors:

  • Leila Bautista

Contributors

  • Samuli Heilala, M.Sc.
  • Stephanie LaBelle
  • Alice-Louise Madden, M.Sci.
  • Veronica Ross
  • Jackie Tang, M.A.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

1 COUNTRY OVERVIEWS

  • 1.1 France
    • 1.1.1 Demographics and Economy
    • 1.1.2 Health Care System
    • 1.1.3 Regulatory Environment
  • 1.2 Germany
    • 1.2.1 Demographics and Economy
    • 1.2.2 Health Care System
    • 1.2.3 Regulatory Environment
  • 1.3 Italy
    • 1.3.1 Demographics and Economy
    • 1.3.2 Health Care System
    • 1.3.3 Regulatory Environment
  • 1.4 Spain
    • 1.4.1 Demographics and Economy
    • 1.4.2 Health Care System
    • 1.4.3 Regulatory Environment
  • 1.5 UK
    • 1.5.1 Demographics and Economy
    • 1.5.2 Health Care System
    • 1.5.3 Regulatory Environment

2 CLINICAL LANDSCAPE

  • 2.1 Background
    • 2.1.1 Varicose Veins
    • 2.1.2 Spider Veins
  • 2.2 Procedure Descriptions
    • 2.2.1 Endovenous Ablation
    • 2.2.2 Surgical Stripping and High Ligation
    • 2.2.3 Phlebectomy
    • 2.2.4 Sclerotherapy
  • 2.3 Competing Treatments
  • 2.4 Guidelines and Diagnosis Patterns
    • 2.4.1 Diagnosis and Referral Patterns
      • Varicose Vein Treatment Assessment and Protocol

3 PRODUCTS

  • 3.1 Endovenous Ablation Devices
  • 3.2 Surgical Stripping Devices
  • 3.3 Phlebectomy Devices
  • 3.4 Sclerotherapy Agents

4 CLINICAL TRIALS

  • 4.1 Endovenous Ablation
  • 4.2 Sclerotherapy

5 VARICOSE VEIN TREATMENT DEVICE MARKET

  • 5.1 Market Snapshot
  • 5.2 Detailed Market Analysis
  • 5.3 Competitive Snapshot
  • 5.4 Detailed Competitive Landscape
  • 5.5 Market Shares
  • 5.6 Recent Events
  • 5.7 Most Promising Emerging Products

6 ENDOVENOUS ABLATION DEVICE MARKET

  • 6.1 Market Snapshot
  • 6.2 Detailed Market Analysis
    • 6.2.1 Endovenous Laser Ablation
    • 6.2.2 Endovenous Radio Frequency Ablation
  • 6.3 Competitive Snapshot
  • 6.4 Detailed Competitive Landscape
  • 6.5 Market Shares

7 SURGICAL STRIPPING DEVICE MARKET

  • 7.1 Market Snapshot
  • 7.2 Detailed Market Analysis
  • 7.3 Competitive Snapshot
  • 7.4 Detailed Competitive Landscape

8 PHLEBECTOMY PROCEDURES

  • 8.1 Procedure Snapshot
  • 8.2 Detailed Procedure Analysis
  • 8.3 Competitive Snapshot

9 SCLEROTHERAPY AGENT MARKET

  • 9.1 Market Snapshot
  • 9.2 Detailed Market Analysis
    • 9.2.1 Primary and Adjunctive Treatments
    • 9.2.2 Spider Vein Treatments
  • 9.3 Competitive Snapshot
  • 9.4 Detailed Competitive Landscape
  • 9.5 Market Shares

APPENDIX: METHODOLOGY

APPENDIX: ACRONYMS AND INITIALISMS

APPENDIX: BIBLIOGRAPHY

LIST OF FIGURES AND TABLES

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

  • Figure 1: Varicose Vein Treatment Device Market, by Product Type, Europe (USD), 2012-2022
  • Table 1: Varicose Vein Treatment Device Market Landscape, Europe (USD), 2013 and 2022
  • Table 2: Varicose Vein Treatment Device Revenue Market Share Rankings, by Product Type, Europe, 2013
  • Table 3: Companies Mentioned
  • Table 4: Factors Impacting the Varicose Vein Treatment Device Market, by Product Type, Europe
  • Table 5: Recent Novel Devices in the Varicose Vein Treatment Device Market, by Product Type, Europe, 2013
  • Table 6: Expected Key Events in the Varicose Vein Treatment Device Market, Europe
  • Table 7: Key Report Updates
  • Table 8: Geographies Covered, Europe
  • Table 9: Average Currency Exchange Rates
  • Table 10: Varicose Vein Treatments Covered, Europe
  • Table 11: Varicose Vein Treatment Devices Covered, Europe

1 COUNTRY OVERVIEWS

  • Table 12: Key Health and Economic Indicators, France
  • Table 13: Key Health and Economic Indicators, Germany
  • Table 14: Key Health and Economic Indicators, Italy
  • Table 15: Key Health and Economic Indicators, Spain
  • Table 16: Key Health and Economic Indicators, UK

2 CLINICAL LANDSCAPE

  • Table 17: Probable Risk Factors for Developing Varicose Veins
  • Table 18: Treatment Providers and Referral Patterns, by Treatment Phase

3 PRODUCTS

  • Table 19: Endovenous Ablation Device Functions, by Product Type
  • Table 20: Comparison of ELA and ERFA Devices
  • Table 21: Surgical Stripping Device Functions, by Product Type
  • Table 22: Phlebectomy Device Functions, by Product Type
  • Table 23: Sclerotherapy Functions, by Agent

4 CLINICAL TRIALS

  • Table 24: RECOVERY
  • Table 25: LARA Study
  • Table 26: VNUS vs. TULIP
  • Table 27: COLA
  • Table 28: RELIEVE
  • Table 29: ClariVein-2
  • Table 30: RAFPELS
  • Table 31: VANISH-1
  • Table 32: VANISH-2
  • Table 33: Varisolve Safety Study
  • Table 34: Side-Effects and Complications of Foam Sclerotherapy of the Great and Small Saphenous Veins
  • Table 35: FOAM

5 VARICOSE VEIN TREATMENT DEVICE MARKET

  • Figure 2: Varicose Vein Treatment Device Market, by Product Type, Europe (USD), 2012-2022
  • Table 36: Factors Impacting the Varicose Vein Treatment Device Market, by Product Type, Europe
  • Table 37: Varicose Vein and Spider Vein Treatments, by Procedure Type, Europe, 2012-2022
  • Table 38: Varicose Vein and Spider Vein Treatments, by Country, Europe, 2012-2022
  • Table 39: Varicose Vein Treatments, by Country, Europe, 2012-2022
  • Table 40: Primary Varicose Vein Treatments, by Technique, Europe, 2012-2022
  • Table 41: Primary Varicose Vein Treatments, by Country, Europe, 2012-2022
  • Table 42: Adjunctive Varicose Vein Treatments, by Technique, Europe, 2012-2022
  • Table 43: Adjunctive Varicose Vein Treatments, by Country, Europe, 2012-2022
  • Table 44: Spider Vein Treatments, by Country, Europe, 2012-2022
  • Table 45: Varicose Vein Treatment Device Market, by Product Type, Europe (USD and EUR), 2012-2022
  • Table 46: Varicose Vein Treatment Device Market, by Country, Europe (USD, EUR, and GBP), 2012-2022
  • Figure 3: Varicose Vein Treatment Device Revenue Market Shares, Europe, 2013
  • Table 47: Varicose Vein Treatment Device Revenue Market Shares, by Product Type, Europe, 2013
  • Table 48: Recent Events in the Varicose Vein Treatment Device Market, Europe
  • Table 49: Emerging Products in Development for the Varicose Vein Treatment Device Market, Europe

6 ENDOVENOUS ABLATION DEVICE MARKET

  • Figure 4: Endovenous Ablation Device Market, by Product Type, Europe (USD), 2012-2022
  • Table 50: Endovenous Ablation Procedures, by Product Type, Europe, 2012-2022
  • Table 51: Endovenous Ablation Procedures, by Country, Europe, 2012-2022
  • Table 52: Endovenous Ablation Device Market, by Product Type, Europe (USD and EUR), 2012-2022
  • Table 53: Endovenous Ablation Device Market, by Country, Europe (USD, EUR, and GBP), 2012-2022
  • Table 54: ELA Procedures, by Country, Europe, 2012-2022
  • Table 55: ELA Device Market, by Component, Europe (USD), 2012-2022
  • Table 56: ELA Device Market, by Component, Europe (EUR), 2012-2022
  • Table 57: ELA Device Market Growth, by Component, Europe, 2013-2022
  • Table 58: ELA Device Market, by Country, Europe (USD, EUR, and GBP), 2012-2022
  • Table 59: ELA Capital Equipment Market, by Country, Europe (USD), 2012-2022
  • Table 60: ELA Capital Equipment Market, by Country, Europe (EUR and GBP), 2012-2022
  • Table 61: ELA Capital Equipment Market Growth, by Country, Europe, 2013-2022
  • Table 62: ELA Capital Equipment Installed Base, by Country, Europe, 2013-2022
  • Table 63: Disposable Laser Fiber Market, by Country, Europe (USD), 2012-2022
  • Table 64: Disposable Laser Fiber Market, by Country, Europe (EUR and GBP), 2012-2022
  • Table 65: Disposable Laser Fiber Market Growth, by Country, Europe, 2013-2022
  • Table 66: ERFA Procedures, by Country, Europe, 2012-2022
  • Table 67: ERFA Device Market, by Component, Europe (USD), 2012-2022
  • Table 68: ERFA Device Market, by Component, Europe (EUR), 2012-2022
  • Table 69: ERFA Device Market Growth, by Component, Europe, 2013-2022
  • Table 70: ERFA Device Market, by Country, Europe (USD, EUR, and GBP), 2012-2022
  • Table 71: ERFA Capital Equipment Market, by Country, Europe (USD), 2012-2022
  • Table 72: ERFA Capital Equipment Market, by Country, Europe (EUR and GBP), 2012-2022
  • Table 73: ERFA Capital Equipment Market Growth, by Country, Europe, 2013-2022
  • Table 74: ERFA Capital Equipment Installed Base, by Country, Europe, 2013-2022
  • Table 75: OEM RF Catheter Market, by Country, Europe (USD), 2012-2022
  • Table 76: OEM RF Catheter Market, by Country, Europe (EUR and GBP), 2012-2022
  • Table 77: OEM RF Catheter Market Growth, by Country, Europe, 2013-2022
  • Figure 5: Endovenous Ablation Device Revenue Market Shares, Europe, 2013
  • Table 78: Endovenous Ablation Device Revenue Market Shares, by Product Type, Europe, 2013
  • Table 79: ERFA Device Revenue Market Shares, by Country, Europe, 2013

7 SURGICAL STRIPPING DEVICE MARKET

  • Figure 6: Surgical Stripping Device Market, by Country, Europe (USD), 2012-2022
  • Table 80: Surgical Stripping Procedures, by Country, Europe, 2012-2022
  • Table 81: Surgical Stripping Procedures using Disposable Strippers, by Country, Europe, 2012-2022
  • Table 82: Surgical Stripping Device Market, by Country, Europe (USD), 2012-2022
  • Table 83: Surgical Stripping Device Market, by Country, Europe (EUR and GBP), 2012-2022
  • Table 84: Surgical Stripping Device Market Growth, by Country, Europe, 2013-2022
  • Table 85: List of Competitors

8 PHLEBECTOMY PROCEDURES

  • Figure 7: Phlebectomy Procedures, by Country, Europe, 2012-2022
  • Table 86: Phlebectomy Procedures, by Country, Europe, 2012-2022
  • Table 87: List of Competitors

9 SCLEROTHERAPY AGENT MARKET

  • Figure 8: Sclerotherapy Agent Market, by Agent, Europe (USD), 2012-2022
  • Table 88: Sclerotherapy Procedures, by Procedure Type, Europe, 2012-2022
  • Table 89: Sclerotherapy Procedures, by Country, Europe, 2012-2022
  • Table 90: Sclerotherapy Agent Market, by Agent, Europe (USD), 2012-2022
  • Table 91: Sclerotherapy Agent Market, by Agent, Europe (EUR), 2012-2022
  • Table 92: Sclerotherapy Agent Market Growth, by Agent, Europe, 2013-2022
  • Table 93: Sclerotherapy Agent Market, by Country, Europe (USD, EUR, and GBP), 2012-2022
  • Table 94: Sclerotherapy Agent Market, by Agent, France (USD), 2012-2022
  • Table 95: Sclerotherapy Agent Market, by Agent, France (EUR), 2012-2022
  • Table 96: Sclerotherapy Agent Market Growth, by Agent, France, 2013-2022
  • Table 97: Sclerotherapy Agent Market, by Agent, Germany (USD), 2012-2022
  • Table 98: Sclerotherapy Agent Market, by Agent, Germany (EUR), 2012-2022
  • Table 99: Sclerotherapy Agent Market Growth, by Agent, Germany, 2013-2022
  • Table 100: Sclerotherapy Agent Market, by Agent, Italy (USD), 2012-2022
  • Table 101: Sclerotherapy Agent Market, by Agent, Italy (EUR), 2012-2022
  • Table 102: Sclerotherapy Agent Market Growth, by Agent, Italy, 2013-2022
  • Table 103: Sclerotherapy Agent Market, Spain (USD and EUR), 2012-2022
  • Table 104: Sclerotherapy Agent Market, by Agent, UK (USD), 2012-2022
  • Table 105: Sclerotherapy Agent Market, by Agent, UK (EUR), 2012-2022
  • Table 106: Sclerotherapy Agent Market, by Agent, UK (GBP), 2012-2022
  • Table 107: Sclerotherapy Agent Market Growth, by Agent, UK, 2013-2022
  • Table 108: Primary and Adjunctive Treatment Sclerotherapy Procedures, by Procedure Type, Europe, 2012-2022
  • Table 109: Primary and Adjunctive Treatment Sclerotherapy Procedures, by Country, Europe, 2012-2022
  • Table 110: Primary Treatment Sclerotherapy Procedures, by Country, Europe, 2012-2022
  • Table 111: Adjunctive Treatment Sclerotherapy Procedures, by Country, Europe, 2012-2022
  • Table 112: Spider Vein Treatment Sclerotherapy Procedures, by Country, Europe, 2012-2022
  • Figure 9: Sclerotherapy Agent Revenue Market Shares, Europe, 2013
  • Table 113: Sclerotherapy Agent Revenue Market Shares, by Country, Europe, 2013

APPENDIX: METHODOLOGY

APPENDIX: ACRONYMS AND INITIALISMS

  • Table 114: Acronyms and Initialisms

APPENDIX: BIBLIOGRAPHY

Back to Top